Non-small cell lung cancer
Conditions
Interventions
Control group:basic treatment
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients underwent thoracoscopic sublobar, lobe, composite lobectomy or pneumonectomy with or without mediastinal lymph node dissection; postoperative pathological diagnosis of primary lung cancer stage I, stage IIA or precancerous lesions; no chest pain before surgery Patients with chest pain; age 18 or older; voluntary participation in clinical trials, signed informed consent, and can be followed up.
Exclusion criteria
Exclusion criteria: Meet the diagnostic criteria of primary bronchogenic lung cancer, but have been treated by radiotherapy, chemotherapy, targeted therapy, Chinese medicine; patients with mental illness such as unconsciousness and communication difficulties; combined with severe heart, liver, kidney, brain Patients with vascular disease; patients with pregnancy planning, pregnancy, lactation; clinical data are incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS digital rating scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30 (version 3) Quality of Life Questionnaire; | — |
Countries
China
Contacts
Public ContactCuiling Feng
Peking University People's Hospital Medical
Outcome results
None listed